can glp 1 cause numbness The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 GLP-1 Medications Infographic | Medidex

Most formulations are administered via subcutaneous injection, either daily or weekly, though oral semaglutide (Rybelsus) is also available for diabetes treatment

A 2023 Phase 2 clinical study on retatrutide published in the New England Journal of Medicine demonstrated significant reductions in body weight in research participants, underscoring its importance as a research compound

In a phase III randomized controlled trial, 966 patients with mild-to-moderate MASH (stage F1b, F2 or F3) were randomly assigned to once-daily oral treatment with 80 mg or 100 mg resmetirom or placebo for 52 weeks 4

Reconstitute a 5 mg vial with 2 mL bacteriostatic water (so 0.1 mL = 250 mcg), refrigerate, and inject at the same time daily for consistency

It plays a role in improving insulin sensitivity, supporting glucose utilization, and enhancing metabolic efficiency at the cellular level

10.1038/s41598-024-76113-6 66 MoughanP